VHAC Bi-Annual Meeting | Friday, November 7, 2014


VHAC Bi-Annual Partner Meeting

The CDC Foundation convened the Bi-Annual Viral Hepatitis Action Coalition (VHAC) Partner Meeting in Boston, MA on November 7, 2014 with U.S. domestic and global topics on prevention and control. The U.S. domestic agenda topics centered on surveillance and evaluation; testing, linkage to care, and treatment, and CDC’s cure and prevention strategies for people who inject drugs. The global agenda focused on CDC’s role in global viral hepatitis prevention and control and progress towards hepatitis C control in Egypt, the country of Georgia, and Pakistan.

Below please find links to presentations from the Meeting for each speaker. Additional meeting materials include the meeting agenda , presenter biosketches , and the participant list .


Population-Based Evaluation Chronic Hepatitis Cohort Study (CHeCS)
Scott Holmberg, MD
Chief, Epidemiology and Surveillance Branch
Division of Viral Hepatitis, NCHHSTP, CDC

Capitalizing on Progressive Adoption of Electronic Medical Records
Bret Shillingstad, MD
Physician, Clinical Informatics
EPIC System Corporation

EPI Profiles: Building Data Collection and Reporting Capacity at the State Level
Catherine Cairns, MPH
Director, Infectious Disease Association of State and Territorial Health Officials

Use of Commercial Lab Data - Initial Findings
Monina Klevens, DDS, MPH
Epidemiologist Division of Viral Hepatitis, NCHHSTP, CDC

Overview of CDC Activities (PWID)
John Zibbell, PhD
Health Scientist/Medical Anthropologist
Division of Viral Hepatitis, NCHHSTP, CDC

Improving the Hepatitis Continuum of Care
Kiren Mitruka, MD, MPH
Medical Epidemiologist
Division of Viral Hepatitis, NCHHSTP, CDC

Potential Impact of an Emergency Department HCV Screening Consortium
James Galbraith, MD, FACEP
Professor, Department of Emergency Medicine
University of Alabama

Hepatitis C Community Alliance for Testing and Treatment (HepCATT)
Daniel Johnson, MD
Director, HepCATT
University of Chicago

State-Wide Access for the Testing and Cure of Hepatitis
Kevin Cranston, MDiv
Director, Bureau of Infectious Disease
Massachusetts Department of Public Health

Improving Identification and Care of HBV in High-Risk Populations
Claudia Vellozzi, MD, MPH
Acting Chief, Prevention Branch
Division of Viral Hepatitis, NCHHSTP, CDC

Global Update

Role of CDC Globally
Francisco Averhoff, MD, MPH
Associate Director of Global Health
Division of Viral Hepatitis, NCHHSTP, CDC

Progress Towards HCV Control in Egypt
Manal Hamdy El-Sayed, MD
Professor, Ain Schams University
Egypt National Committee for Control of Hepatitis

Wahid Doss, MD
Dean, National Liver Institute - Egypt
Ministry of Health

Progress Towards HCV Control in Pakistan
Huma Qureshi, MD
Executive Director
Pakistan Medical Research Council

Progress Towards HCV Control in Georgia
David Sergeenko, MD
Minister of Labor, Health, and Social Affairs of Georgia

Strategic Priorities of WHO
Stefan Wiktor, MD
Medical Officer
Global Hepatitis Programme, World Health Organization